Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 17 | 2017 | 151 | 4.850 |
Why?
|
Women's Health | 27 | 2022 | 174 | 3.010 |
Why?
|
Depression | 19 | 2018 | 444 | 3.010 |
Why?
|
Intra-Abdominal Fat | 9 | 2016 | 40 | 2.460 |
Why?
|
Patient Compliance | 11 | 2017 | 150 | 2.250 |
Why?
|
Asthma | 6 | 2015 | 157 | 2.130 |
Why?
|
Obesity | 12 | 2022 | 311 | 1.940 |
Why?
|
Middle Aged | 95 | 2022 | 8923 | 1.900 |
Why?
|
Menopause | 18 | 2018 | 101 | 1.870 |
Why?
|
Self Care | 9 | 2016 | 89 | 1.820 |
Why?
|
Medication Adherence | 6 | 2016 | 49 | 1.810 |
Why?
|
Behavior Therapy | 11 | 2023 | 86 | 1.730 |
Why?
|
Female | 105 | 2022 | 15213 | 1.720 |
Why?
|
Humans | 126 | 2023 | 27074 | 1.520 |
Why?
|
Social Support | 14 | 2018 | 196 | 1.490 |
Why?
|
Patient Education as Topic | 8 | 2011 | 131 | 1.430 |
Why?
|
Obesity, Abdominal | 4 | 2015 | 19 | 1.300 |
Why?
|
Adrenal Cortex Hormones | 3 | 2015 | 115 | 1.240 |
Why?
|
Cardiovascular Diseases | 12 | 2016 | 321 | 1.230 |
Why?
|
Exercise | 5 | 2018 | 450 | 1.220 |
Why?
|
Myocardial Infarction | 19 | 2009 | 133 | 1.160 |
Why?
|
Risk Factors | 38 | 2022 | 2302 | 1.060 |
Why?
|
Stress, Psychological | 10 | 2012 | 235 | 1.050 |
Why?
|
Adiposity | 7 | 2017 | 43 | 1.050 |
Why?
|
Guideline Adherence | 3 | 2017 | 56 | 1.040 |
Why?
|
Quality of Life | 6 | 2016 | 629 | 1.020 |
Why?
|
Depressive Disorder | 11 | 2018 | 177 | 0.970 |
Why?
|
Hospitalization | 8 | 2016 | 300 | 0.960 |
Why?
|
Male | 49 | 2022 | 14772 | 0.930 |
Why?
|
Disease Management | 2 | 2017 | 102 | 0.890 |
Why?
|
Body Mass Index | 12 | 2017 | 458 | 0.890 |
Why?
|
Life Style | 9 | 2018 | 186 | 0.880 |
Why?
|
Prejudice | 4 | 2013 | 34 | 0.880 |
Why?
|
Adult | 41 | 2022 | 7831 | 0.880 |
Why?
|
Poverty | 4 | 2016 | 96 | 0.880 |
Why?
|
Healthcare Disparities | 3 | 2015 | 88 | 0.860 |
Why?
|
Spirituality | 4 | 2009 | 80 | 0.850 |
Why?
|
Minority Groups | 7 | 2018 | 80 | 0.840 |
Why?
|
Chicago | 14 | 2016 | 949 | 0.840 |
Why?
|
Urban Population | 3 | 2015 | 153 | 0.820 |
Why?
|
Breast Neoplasms | 5 | 2013 | 409 | 0.810 |
Why?
|
Smoking Cessation | 1 | 2023 | 47 | 0.800 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2014 | 164 | 0.800 |
Why?
|
Mexican Americans | 2 | 2013 | 26 | 0.800 |
Why?
|
Atherosclerosis | 4 | 2018 | 53 | 0.800 |
Why?
|
Weight Reduction Programs | 2 | 2022 | 21 | 0.790 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 49 | 0.790 |
Why?
|
Community Health Workers | 2 | 2013 | 35 | 0.780 |
Why?
|
Socioeconomic Factors | 15 | 2017 | 302 | 0.770 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2015 | 231 | 0.770 |
Why?
|
Metabolic Syndrome | 3 | 2018 | 58 | 0.760 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2013 | 167 | 0.730 |
Why?
|
United States | 29 | 2019 | 2035 | 0.720 |
Why?
|
Coronary Artery Disease | 8 | 2022 | 135 | 0.710 |
Why?
|
Health Behavior | 4 | 2013 | 159 | 0.700 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2013 | 30 | 0.670 |
Why?
|
Health Status | 6 | 2011 | 218 | 0.640 |
Why?
|
Hostility | 6 | 2009 | 24 | 0.640 |
Why?
|
Absorptiometry, Photon | 4 | 2015 | 84 | 0.630 |
Why?
|
Physician-Patient Relations | 3 | 2017 | 44 | 0.630 |
Why?
|
Exercise Therapy | 2 | 2018 | 88 | 0.620 |
Why?
|
Postmenopause | 10 | 2017 | 54 | 0.620 |
Why?
|
Body Fat Distribution | 3 | 2016 | 12 | 0.620 |
Why?
|
Personal Satisfaction | 2 | 2016 | 43 | 0.620 |
Why?
|
Diet Therapy | 1 | 2018 | 10 | 0.610 |
Why?
|
Surveys and Questionnaires | 13 | 2016 | 1144 | 0.610 |
Why?
|
Cross-Sectional Studies | 15 | 2016 | 891 | 0.610 |
Why?
|
Counseling | 7 | 2013 | 42 | 0.600 |
Why?
|
Treatment Outcome | 14 | 2017 | 3485 | 0.590 |
Why?
|
Cohort Studies | 16 | 2016 | 1890 | 0.570 |
Why?
|
Follow-Up Studies | 20 | 2017 | 1792 | 0.570 |
Why?
|
Carotid Intima-Media Thickness | 2 | 2018 | 18 | 0.550 |
Why?
|
Mass Screening | 3 | 2016 | 167 | 0.540 |
Why?
|
Hydrocortisone | 2 | 2010 | 39 | 0.540 |
Why?
|
Food Services | 1 | 2016 | 2 | 0.540 |
Why?
|
Child Nutrition Sciences | 1 | 2016 | 3 | 0.540 |
Why?
|
Diet Records | 1 | 2016 | 11 | 0.530 |
Why?
|
Aged | 24 | 2019 | 8997 | 0.530 |
Why?
|
Coronary Disease | 9 | 2013 | 50 | 0.530 |
Why?
|
Data Collection | 2 | 2016 | 91 | 0.530 |
Why?
|
Motor Activity | 2 | 2009 | 323 | 0.530 |
Why?
|
Chronic Disease | 5 | 2016 | 415 | 0.520 |
Why?
|
Abdominal Fat | 2 | 2015 | 8 | 0.520 |
Why?
|
Schools | 1 | 2016 | 43 | 0.520 |
Why?
|
Assertiveness | 2 | 2015 | 7 | 0.520 |
Why?
|
Longitudinal Studies | 18 | 2019 | 1368 | 0.510 |
Why?
|
Diet, Sodium-Restricted | 1 | 2016 | 11 | 0.510 |
Why?
|
Self Efficacy | 2 | 2014 | 53 | 0.500 |
Why?
|
Psychotherapy | 1 | 2016 | 39 | 0.500 |
Why?
|
Adolescent | 7 | 2016 | 2172 | 0.500 |
Why?
|
Lung Diseases | 1 | 2015 | 45 | 0.480 |
Why?
|
Wounds and Injuries | 1 | 2015 | 45 | 0.480 |
Why?
|
Comorbidity | 8 | 2016 | 481 | 0.480 |
Why?
|
Directive Counseling | 2 | 2016 | 12 | 0.480 |
Why?
|
Child | 6 | 2016 | 1295 | 0.470 |
Why?
|
Primary Health Care | 1 | 2016 | 83 | 0.470 |
Why?
|
Health Status Disparities | 2 | 2015 | 75 | 0.470 |
Why?
|
Heart Diseases | 1 | 2015 | 62 | 0.470 |
Why?
|
Adipose Tissue | 5 | 2019 | 76 | 0.460 |
Why?
|
Anti-Asthmatic Agents | 1 | 2015 | 31 | 0.460 |
Why?
|
Depressive Disorder, Major | 1 | 2015 | 100 | 0.450 |
Why?
|
Odds Ratio | 9 | 2016 | 270 | 0.440 |
Why?
|
Calcinosis | 5 | 2016 | 45 | 0.440 |
Why?
|
Social Perception | 1 | 2013 | 12 | 0.430 |
Why?
|
Vascular Calcification | 3 | 2022 | 9 | 0.420 |
Why?
|
Carotid Artery Diseases | 3 | 2009 | 15 | 0.420 |
Why?
|
Coronary Vessels | 6 | 2022 | 34 | 0.420 |
Why?
|
Logistic Models | 10 | 2014 | 395 | 0.410 |
Why?
|
Telemedicine | 1 | 2015 | 97 | 0.410 |
Why?
|
Blood Pressure | 3 | 2013 | 195 | 0.410 |
Why?
|
Subcutaneous Fat | 2 | 2009 | 8 | 0.400 |
Why?
|
MP3-Player | 2 | 2013 | 5 | 0.400 |
Why?
|
Type A Personality | 9 | 1992 | 9 | 0.400 |
Why?
|
Age Factors | 7 | 2019 | 766 | 0.380 |
Why?
|
Educational Status | 6 | 2009 | 293 | 0.380 |
Why?
|
Body Weight | 2 | 2018 | 134 | 0.380 |
Why?
|
Research Design | 2 | 2013 | 185 | 0.370 |
Why?
|
Testosterone | 5 | 2015 | 28 | 0.360 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 161 | 0.350 |
Why?
|
Prevalence | 7 | 2016 | 443 | 0.350 |
Why?
|
Practice Patterns, Physicians' | 1 | 2011 | 111 | 0.340 |
Why?
|
Religion and Medicine | 3 | 2011 | 25 | 0.340 |
Why?
|
Mammography | 2 | 2013 | 47 | 0.330 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 261 | 0.330 |
Why?
|
Attitude to Health | 3 | 2011 | 99 | 0.330 |
Why?
|
Circadian Rhythm | 2 | 2010 | 235 | 0.320 |
Why?
|
Religion | 2 | 2009 | 41 | 0.320 |
Why?
|
Hysterectomy | 2 | 2009 | 23 | 0.320 |
Why?
|
Patient Participation | 2 | 2008 | 47 | 0.320 |
Why?
|
Psychophysiology | 1 | 2009 | 6 | 0.310 |
Why?
|
Life Change Events | 2 | 2004 | 37 | 0.310 |
Why?
|
Hypertension | 2 | 2014 | 192 | 0.310 |
Why?
|
Menstrual Cycle | 2 | 2005 | 19 | 0.310 |
Why?
|
Pain | 3 | 2009 | 413 | 0.310 |
Why?
|
Diet | 1 | 2010 | 220 | 0.300 |
Why?
|
Health Education | 1 | 2008 | 48 | 0.300 |
Why?
|
Disease Progression | 7 | 2022 | 673 | 0.300 |
Why?
|
Prospective Studies | 8 | 2018 | 1778 | 0.290 |
Why?
|
Single-Blind Method | 3 | 2013 | 102 | 0.290 |
Why?
|
Tomography, X-Ray Computed | 9 | 2022 | 683 | 0.270 |
Why?
|
Personal Autonomy | 2 | 2018 | 10 | 0.270 |
Why?
|
Clinical Trials as Topic | 3 | 2010 | 216 | 0.270 |
Why?
|
Overweight | 4 | 2022 | 72 | 0.270 |
Why?
|
Estradiol | 5 | 2015 | 53 | 0.260 |
Why?
|
Sex Factors | 8 | 2009 | 464 | 0.260 |
Why?
|
Gonadal Hormones | 1 | 2005 | 2 | 0.250 |
Why?
|
Smoking | 2 | 2023 | 176 | 0.250 |
Why?
|
Meals | 2 | 2016 | 11 | 0.250 |
Why?
|
Severity of Illness Index | 6 | 2010 | 879 | 0.250 |
Why?
|
Uterine Diseases | 1 | 2005 | 2 | 0.250 |
Why?
|
Health Services Misuse | 1 | 2005 | 2 | 0.250 |
Why?
|
Vulnerable Populations | 1 | 2005 | 23 | 0.240 |
Why?
|
Acculturation | 1 | 2005 | 31 | 0.240 |
Why?
|
Multilingualism | 1 | 2005 | 21 | 0.240 |
Why?
|
Language | 1 | 2005 | 63 | 0.240 |
Why?
|
Sexual Partners | 1 | 2004 | 17 | 0.230 |
Why?
|
Prognosis | 7 | 2018 | 785 | 0.230 |
Why?
|
Affect | 1 | 2005 | 60 | 0.230 |
Why?
|
Sexual Behavior | 1 | 2004 | 54 | 0.230 |
Why?
|
Stroke Volume | 2 | 2014 | 54 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 2 | 2004 | 77 | 0.220 |
Why?
|
Social Class | 2 | 2016 | 67 | 0.220 |
Why?
|
Self Report | 2 | 2016 | 223 | 0.220 |
Why?
|
Administration, Inhalation | 2 | 2013 | 37 | 0.220 |
Why?
|
Arousal | 3 | 2002 | 50 | 0.210 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 255 | 0.210 |
Why?
|
Sex Hormone-Binding Globulin | 4 | 2011 | 16 | 0.210 |
Why?
|
Hormone Replacement Therapy | 3 | 2013 | 35 | 0.210 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2013 | 8 | 0.200 |
Why?
|
Sleep | 1 | 2005 | 328 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 18 | 0.200 |
Why?
|
Perimenopause | 3 | 2008 | 15 | 0.200 |
Why?
|
Norepinephrine | 1 | 2002 | 30 | 0.200 |
Why?
|
Caregivers | 1 | 2004 | 197 | 0.190 |
Why?
|
Epinephrine | 1 | 2002 | 32 | 0.190 |
Why?
|
Motivation | 2 | 2014 | 85 | 0.190 |
Why?
|
Psychophysiologic Disorders | 1 | 2001 | 6 | 0.190 |
Why?
|
Weight Loss | 2 | 2022 | 127 | 0.190 |
Why?
|
Premenopause | 2 | 2017 | 11 | 0.190 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 139 | 0.180 |
Why?
|
Patient Care Team | 2 | 2016 | 119 | 0.180 |
Why?
|
Psychotherapy, Group | 2 | 2013 | 40 | 0.180 |
Why?
|
Confidence Intervals | 3 | 2011 | 94 | 0.170 |
Why?
|
Hot Flashes | 3 | 2011 | 11 | 0.170 |
Why?
|
Aged, 80 and over | 5 | 2018 | 4777 | 0.170 |
Why?
|
Hospital Mortality | 1 | 2001 | 130 | 0.170 |
Why?
|
Health Surveys | 3 | 2009 | 86 | 0.170 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 7 | 0.170 |
Why?
|
Cardiovascular System | 1 | 2019 | 14 | 0.160 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2014 | 310 | 0.160 |
Why?
|
Walking Speed | 1 | 2019 | 41 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2013 | 329 | 0.160 |
Why?
|
Psychological Tests | 2 | 2009 | 52 | 0.160 |
Why?
|
Biomarkers | 1 | 2002 | 562 | 0.160 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 474 | 0.160 |
Why?
|
Advance Care Planning | 1 | 2018 | 11 | 0.150 |
Why?
|
Goals | 1 | 2018 | 43 | 0.150 |
Why?
|
Alcohol Drinking | 2 | 2010 | 75 | 0.140 |
Why?
|
Recurrence | 10 | 2007 | 310 | 0.140 |
Why?
|
Waist-Height Ratio | 1 | 2016 | 5 | 0.130 |
Why?
|
Metabolic Diseases | 1 | 2016 | 8 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2013 | 292 | 0.130 |
Why?
|
Food Preferences | 1 | 2016 | 18 | 0.130 |
Why?
|
Tunica Intima | 3 | 2011 | 11 | 0.130 |
Why?
|
Multiple Chronic Conditions | 1 | 2016 | 6 | 0.130 |
Why?
|
Illinois | 2 | 2009 | 250 | 0.130 |
Why?
|
Ear, External | 1 | 1996 | 2 | 0.130 |
Why?
|
Patient Care Management | 1 | 2016 | 16 | 0.130 |
Why?
|
Ultrasonography | 4 | 2018 | 227 | 0.130 |
Why?
|
Patient Health Questionnaire | 1 | 2016 | 12 | 0.130 |
Why?
|
Propensity Score | 1 | 2016 | 36 | 0.130 |
Why?
|
Climacteric | 1 | 2015 | 4 | 0.130 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2013 | 4 | 0.130 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2013 | 4 | 0.130 |
Why?
|
Community Mental Health Services | 1 | 2015 | 15 | 0.120 |
Why?
|
Estrogens | 2 | 2013 | 25 | 0.120 |
Why?
|
Role | 2 | 2012 | 8 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 175 | 0.120 |
Why?
|
New Jersey | 2 | 2005 | 3 | 0.120 |
Why?
|
Antidepressive Agents | 2 | 2007 | 97 | 0.120 |
Why?
|
Parents | 1 | 2016 | 113 | 0.120 |
Why?
|
Research | 1 | 2015 | 39 | 0.120 |
Why?
|
Smartphone | 1 | 2015 | 15 | 0.120 |
Why?
|
Health Policy | 1 | 2015 | 42 | 0.120 |
Why?
|
Pilot Projects | 4 | 2014 | 420 | 0.120 |
Why?
|
Cost of Illness | 1 | 2015 | 50 | 0.120 |
Why?
|
Mobile Applications | 1 | 2015 | 29 | 0.120 |
Why?
|
Lipoproteins, HDL | 2 | 2014 | 23 | 0.110 |
Why?
|
Quality Improvement | 1 | 2015 | 138 | 0.110 |
Why?
|
Reproducibility of Results | 1 | 2016 | 676 | 0.110 |
Why?
|
Carotid Arteries | 2 | 2011 | 15 | 0.110 |
Why?
|
Weight Gain | 2 | 2007 | 64 | 0.110 |
Why?
|
Tunica Media | 2 | 2011 | 5 | 0.110 |
Why?
|
Vaginal Smears | 1 | 2013 | 11 | 0.110 |
Why?
|
Papanicolaou Test | 1 | 2013 | 9 | 0.110 |
Why?
|
Body Image | 1 | 2014 | 27 | 0.110 |
Why?
|
New York | 1 | 2013 | 10 | 0.110 |
Why?
|
Survival Rate | 2 | 2012 | 342 | 0.110 |
Why?
|
Peer Group | 1 | 2013 | 35 | 0.110 |
Why?
|
Community Health Services | 1 | 2013 | 34 | 0.100 |
Why?
|
Social Environment | 2 | 1992 | 76 | 0.100 |
Why?
|
Cross-Cultural Comparison | 2 | 2010 | 39 | 0.100 |
Why?
|
Organ Size | 2 | 2009 | 95 | 0.100 |
Why?
|
Health Status Indicators | 1 | 2013 | 72 | 0.100 |
Why?
|
Interviews as Topic | 3 | 2018 | 132 | 0.100 |
Why?
|
Personality Assessment | 1 | 1992 | 35 | 0.100 |
Why?
|
Early Detection of Cancer | 1 | 2013 | 102 | 0.100 |
Why?
|
Time Factors | 5 | 2014 | 1433 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 26 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 4 | 0.090 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 10 | 0.090 |
Why?
|
School Health Services | 1 | 2011 | 19 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2017 | 3538 | 0.090 |
Why?
|
Students | 1 | 2011 | 48 | 0.090 |
Why?
|
Adaptation, Psychological | 3 | 2009 | 175 | 0.090 |
Why?
|
Waist-Hip Ratio | 1 | 2010 | 13 | 0.090 |
Why?
|
Coronary Angiography | 3 | 2017 | 74 | 0.090 |
Why?
|
Nutrition Policy | 1 | 2010 | 9 | 0.090 |
Why?
|
Sertraline | 2 | 2007 | 24 | 0.090 |
Why?
|
France | 1 | 2010 | 12 | 0.090 |
Why?
|
Saliva | 1 | 2010 | 52 | 0.090 |
Why?
|
Fruit | 1 | 2010 | 27 | 0.090 |
Why?
|
Vegetables | 1 | 2010 | 26 | 0.090 |
Why?
|
Linear Models | 1 | 2011 | 247 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 33 | 0.090 |
Why?
|
Dietary Fats | 1 | 2010 | 39 | 0.080 |
Why?
|
Morbidity | 3 | 2008 | 54 | 0.080 |
Why?
|
Energy Intake | 1 | 2010 | 83 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2008 | 406 | 0.080 |
Why?
|
Communication | 2 | 2007 | 104 | 0.080 |
Why?
|
Vitamin D | 1 | 2010 | 39 | 0.080 |
Why?
|
California | 2 | 2005 | 34 | 0.080 |
Why?
|
Leiomyoma | 1 | 2009 | 5 | 0.080 |
Why?
|
Down-Regulation | 1 | 2009 | 99 | 0.080 |
Why?
|
Uterus | 1 | 2009 | 18 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2009 | 11 | 0.080 |
Why?
|
Physical Fitness | 1 | 2009 | 51 | 0.080 |
Why?
|
Cognition | 2 | 2010 | 1339 | 0.080 |
Why?
|
Pain Measurement | 2 | 2009 | 483 | 0.080 |
Why?
|
Models, Statistical | 1 | 2009 | 127 | 0.080 |
Why?
|
Aging | 4 | 2009 | 1544 | 0.080 |
Why?
|
Body Composition | 1 | 2009 | 68 | 0.080 |
Why?
|
Insulin Resistance | 2 | 2009 | 50 | 0.080 |
Why?
|
Behavioral Medicine | 1 | 2008 | 6 | 0.080 |
Why?
|
Meditation | 1 | 2009 | 22 | 0.080 |
Why?
|
Demography | 2 | 2006 | 72 | 0.080 |
Why?
|
Carotid Artery, Common | 1 | 2008 | 3 | 0.070 |
Why?
|
Death, Sudden | 1 | 1988 | 7 | 0.070 |
Why?
|
Diagnosis-Related Groups | 1 | 1988 | 8 | 0.070 |
Why?
|
Regression Analysis | 2 | 2005 | 260 | 0.070 |
Why?
|
Behavior | 2 | 1985 | 25 | 0.070 |
Why?
|
Animals | 1 | 2015 | 3642 | 0.070 |
Why?
|
Music | 1 | 2008 | 23 | 0.070 |
Why?
|
Vitamins | 1 | 2007 | 19 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2007 | 7 | 0.070 |
Why?
|
Activities of Daily Living | 2 | 2009 | 595 | 0.070 |
Why?
|
Anti-Obesity Agents | 1 | 2007 | 4 | 0.070 |
Why?
|
Calcium, Dietary | 1 | 2007 | 13 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
Follicle Stimulating Hormone | 3 | 2015 | 22 | 0.070 |
Why?
|
Self Concept | 3 | 2002 | 37 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2004 | 347 | 0.070 |
Why?
|
Incidence | 3 | 2017 | 759 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2007 | 88 | 0.070 |
Why?
|
Sweating | 1 | 2006 | 2 | 0.070 |
Why?
|
Mortality | 2 | 2007 | 89 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2007 | 52 | 0.060 |
Why?
|
Sleep Disorders, Intrinsic | 1 | 2005 | 4 | 0.060 |
Why?
|
Focus Groups | 1 | 2006 | 87 | 0.060 |
Why?
|
Communication Barriers | 1 | 2005 | 4 | 0.060 |
Why?
|
Attitude | 2 | 2002 | 34 | 0.060 |
Why?
|
Social Behavior | 1 | 2006 | 67 | 0.060 |
Why?
|
Risk | 4 | 2013 | 205 | 0.060 |
Why?
|
Masturbation | 1 | 2004 | 1 | 0.060 |
Why?
|
Pennsylvania | 1 | 2004 | 7 | 0.060 |
Why?
|
Reinforcement, Social | 1 | 2004 | 1 | 0.060 |
Why?
|
Breast Self-Examination | 1 | 2004 | 3 | 0.060 |
Why?
|
Utilization Review | 1 | 2004 | 4 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2004 | 105 | 0.060 |
Why?
|
Health Promotion | 1 | 2006 | 143 | 0.060 |
Why?
|
Hand Strength | 1 | 2004 | 58 | 0.060 |
Why?
|
Interpersonal Relations | 1 | 2004 | 101 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2004 | 94 | 0.050 |
Why?
|
Young Adult | 1 | 2009 | 1994 | 0.050 |
Why?
|
Men | 1 | 2022 | 4 | 0.050 |
Why?
|
Occupations | 1 | 2022 | 18 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 383 | 0.050 |
Why?
|
Death | 1 | 2003 | 47 | 0.050 |
Why?
|
Divorce | 1 | 2002 | 2 | 0.050 |
Why?
|
Sympathetic Nervous System | 1 | 2002 | 13 | 0.050 |
Why?
|
Psychology | 1 | 2002 | 21 | 0.050 |
Why?
|
Reference Values | 1 | 2002 | 186 | 0.050 |
Why?
|
Sleep Wake Disorders | 1 | 2003 | 123 | 0.050 |
Why?
|
Electrocardiography | 2 | 2016 | 100 | 0.040 |
Why?
|
Random Allocation | 4 | 1988 | 124 | 0.040 |
Why?
|
Analysis of Variance | 2 | 1993 | 260 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2013 | 161 | 0.040 |
Why?
|
Neoplasms | 1 | 2003 | 237 | 0.040 |
Why?
|
Risk Assessment | 2 | 2017 | 624 | 0.040 |
Why?
|
Inpatients | 1 | 2001 | 125 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2006 | 985 | 0.040 |
Why?
|
Emotions | 1 | 1999 | 72 | 0.040 |
Why?
|
Mental Disorders | 1 | 2001 | 141 | 0.040 |
Why?
|
Pulse Wave Analysis | 1 | 2018 | 4 | 0.040 |
Why?
|
Vascular Stiffness | 1 | 2018 | 4 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2007 | 300 | 0.040 |
Why?
|
Age Distribution | 2 | 2009 | 85 | 0.030 |
Why?
|
Pericardium | 1 | 2017 | 20 | 0.030 |
Why?
|
Decision Making | 1 | 2018 | 223 | 0.030 |
Why?
|
Personality Inventory | 2 | 2007 | 73 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 1995 | 12 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 1996 | 174 | 0.030 |
Why?
|
Policy Making | 1 | 2015 | 12 | 0.030 |
Why?
|
Epidemiologic Research Design | 1 | 2015 | 15 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2015 | 25 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 43 | 0.030 |
Why?
|
Heart Arrest | 1 | 1995 | 39 | 0.030 |
Why?
|
Waist Circumference | 1 | 2014 | 35 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 20 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2010 | 1196 | 0.030 |
Why?
|
Biomedical Research | 1 | 2015 | 56 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2015 | 112 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2014 | 220 | 0.030 |
Why?
|
Population Surveillance | 1 | 2014 | 115 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2013 | 2 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 13 | 0.030 |
Why?
|
Income | 2 | 2004 | 80 | 0.030 |
Why?
|
Hip Fractures | 1 | 2013 | 26 | 0.030 |
Why?
|
Radiography | 1 | 2015 | 619 | 0.030 |
Why?
|
Survival Analysis | 2 | 2004 | 257 | 0.030 |
Why?
|
Psychometrics | 2 | 2003 | 220 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2013 | 63 | 0.030 |
Why?
|
Exercise Test | 1 | 2013 | 118 | 0.030 |
Why?
|
Cholesterol, HDL | 2 | 2010 | 26 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 110 | 0.020 |
Why?
|
Vasomotor System | 1 | 2011 | 3 | 0.020 |
Why?
|
Religion and Psychology | 1 | 2011 | 24 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 43 | 0.020 |
Why?
|
Calcifediol | 1 | 2010 | 2 | 0.020 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2010 | 2 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 261 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 39 | 0.020 |
Why?
|
Particle Size | 1 | 2010 | 50 | 0.020 |
Why?
|
Biological Availability | 1 | 2009 | 17 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2009 | 15 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 34 | 0.020 |
Why?
|
Uterine Prolapse | 1 | 2009 | 3 | 0.020 |
Why?
|
Calcium | 1 | 2012 | 371 | 0.020 |
Why?
|
Videotape Recording | 2 | 1985 | 19 | 0.020 |
Why?
|
Connective Tissue | 1 | 2008 | 24 | 0.020 |
Why?
|
Cholesterol | 2 | 1985 | 64 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 333 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2006 | 19 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2006 | 56 | 0.020 |
Why?
|
Anger | 1 | 2006 | 33 | 0.020 |
Why?
|
Skin Pigmentation | 1 | 1985 | 5 | 0.010 |
Why?
|
Anxiety | 1 | 2006 | 156 | 0.010 |
Why?
|
Interview, Psychological | 1 | 1985 | 41 | 0.010 |
Why?
|
Body Constitution | 1 | 2004 | 3 | 0.010 |
Why?
|
Estrone | 1 | 2004 | 8 | 0.010 |
Why?
|
Pregnanediol | 1 | 2004 | 7 | 0.010 |
Why?
|
Corpus Luteum | 1 | 2004 | 5 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2004 | 12 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2006 | 214 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 482 | 0.010 |
Why?
|
Blood Glucose | 1 | 2004 | 104 | 0.010 |
Why?
|
Acute Disease | 1 | 2003 | 176 | 0.010 |
Why?
|
Memory | 1 | 2003 | 297 | 0.010 |
Why?
|
Telephone | 1 | 2001 | 26 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1999 | 116 | 0.010 |
Why?
|
Mental Health | 1 | 1999 | 108 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 1995 | 65 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 1995 | 44 | 0.010 |
Why?
|
Personality Tests | 1 | 1991 | 5 | 0.010 |
Why?
|
Sick Role | 1 | 1989 | 15 | 0.010 |
Why?
|
Insurance, Health | 1 | 1989 | 21 | 0.010 |
Why?
|
Employment | 1 | 1989 | 38 | 0.000 |
Why?
|
Time Perception | 1 | 1985 | 5 | 0.000 |
Why?
|
Military Medicine | 1 | 1985 | 8 | 0.000 |
Why?
|
Marriage | 1 | 1985 | 6 | 0.000 |
Why?
|
Leadership | 1 | 1985 | 92 | 0.000 |
Why?
|
Group Processes | 1 | 1984 | 14 | 0.000 |
Why?
|